Detalhe da pesquisa
1.
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
BMC Med Res Methodol
; 22(1): 155, 2022 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35637426
2.
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.
Eur J Neurol
; 26(2): 363-370, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30298572
3.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Eur J Neurol
; 23(4): 729-36, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26782663
4.
Assessing the growth of Escherichia coli O157:H7 and Salmonella in spinach, lettuce, parsley and chard extracts at different storage temperatures.
J Appl Microbiol
; 120(6): 1701-10, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26950043
5.
BREMSO: a simple score to predict early the natural course of multiple sclerosis.
Eur J Neurol
; 22(6): 981-9, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25808578
6.
Spanish consensus on the use of natalizumab (Tysabri®)-2013.
Neurologia
; 30(5): 302-14, 2015 Jun.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-24360652
7.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Mult Scler
; 20(7): 877-81, 2014 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24293455
8.
Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.
Neurologia
; 29(4): 210-7, 2014 May.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-24161412
9.
Sleep disorders in patients with multiple sclerosis in Spain.
Neurologia (Engl Ed)
; 39(1): 29-35, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38161070
10.
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
J Med Econ
; 27(1): 109-125, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38085684
11.
Fluctuations of MS births and UV-light exposure.
Acta Neurol Scand
; 127(5): 301-8, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22970985
12.
Modelling survival kinetics of Staphylococcus aureus and Escherichia coli O157:H7 on stainless steel surfaces soiled with different substrates under static conditions of temperature and relative humidity.
Food Microbiol
; 33(2): 197-204, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23200652
13.
High levels of polymorphism found through cross-amplification of microsatellite loci in a Ctenomys pearsoni (Rodentia, Ctenomyidae) population.
Genet Mol Res
; 12(2): 887-91, 2013 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-23613235
14.
Carotid artery stenting: clinical and procedural implications for near-occlusion stenosis.
Neurologia
; 28(9): 535-42, 2013.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-23465685
15.
[Recommendations for the clinical use of motor evoked potentials in multiple sclerosis]. / Recomendaciones para la utilización clínica del estudio de potenciales evocados motores en la esclerosis múltiple.
Neurologia
; 28(7): 408-16, 2013 Sep.
Artigo
Espanhol
| MEDLINE | ID: mdl-22995526
16.
A systematic review of the application of machine-learning algorithms in multiple sclerosis.
Neurologia (Engl Ed)
; 38(8): 577-590, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35843587
17.
Functional phenotypic plasticity mediated by water stress and [CO2] explains differences in drought tolerance of two phylogenetically close conifers.
Tree Physiol
; 43(6): 909-924, 2023 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36809504
18.
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
Genes Immun
; 13(3): 253-7, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22130326
19.
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.
Genes Immun
; 13(1): 21-8, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21716315
20.
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Mult Scler
; 18(7): 983-90, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22183936